IL98542A - Benzoquinazoline derivatives their preparation and pharmaceutical compositions containing them - Google Patents

Benzoquinazoline derivatives their preparation and pharmaceutical compositions containing them

Info

Publication number
IL98542A
IL98542A IL9854291A IL9854291A IL98542A IL 98542 A IL98542 A IL 98542A IL 9854291 A IL9854291 A IL 9854291A IL 9854291 A IL9854291 A IL 9854291A IL 98542 A IL98542 A IL 98542A
Authority
IL
Israel
Prior art keywords
group
methyl
amino
compound
formula
Prior art date
Application number
IL9854291A
Other languages
English (en)
Other versions
IL98542A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL98542A0 publication Critical patent/IL98542A0/xx
Publication of IL98542A publication Critical patent/IL98542A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/86—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88—Oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
IL9854291A 1990-06-19 1991-06-18 Benzoquinazoline derivatives their preparation and pharmaceutical compositions containing them IL98542A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909013615A GB9013615D0 (en) 1990-06-19 1990-06-19 Pharmaceutical compounds

Publications (2)

Publication Number Publication Date
IL98542A0 IL98542A0 (en) 1992-07-15
IL98542A true IL98542A (en) 1995-05-26

Family

ID=10677828

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9854291A IL98542A (en) 1990-06-19 1991-06-18 Benzoquinazoline derivatives their preparation and pharmaceutical compositions containing them

Country Status (26)

Country Link
US (4) US6090941A (de)
EP (2) EP0535034B1 (de)
JP (1) JP2966929B2 (de)
KR (1) KR0183042B1 (de)
CN (1) CN1049215C (de)
AP (1) AP218A (de)
AT (2) ATE222243T1 (de)
AU (1) AU639815B2 (de)
CA (1) CA2085589C (de)
CS (1) CS186391A3 (de)
DE (2) DE69133088T2 (de)
DK (2) DK1199307T3 (de)
ES (2) ES2211851T3 (de)
FI (1) FI925778A7 (de)
GB (1) GB9013615D0 (de)
HU (2) HUT62273A (de)
IE (1) IE912073A1 (de)
IL (1) IL98542A (de)
MC (1) MC2290A1 (de)
MY (1) MY107001A (de)
NO (1) NO924929D0 (de)
NZ (1) NZ238582A (de)
PL (1) PL169927B1 (de)
PT (1) PT98021B (de)
WO (1) WO1991019700A1 (de)
ZA (1) ZA914676B (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6762188B1 (en) 1990-06-19 2004-07-13 Smithkline Beecham Corporation Pharmaceutically active benzoquinazoline compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
GB9223352D0 (en) * 1992-11-06 1992-12-23 Ici Plc Tricyclic compounds
GB9226842D0 (en) * 1992-12-23 1993-02-17 Wellcome Found Pharmaceutical compounds
GB9408936D0 (en) * 1994-05-05 1994-06-22 Cancer Res Inst Anti-cancer compounds
WO2000055166A1 (en) 1999-03-16 2000-09-21 Regents Of The University Of California Glycosylated polyamines
US6531454B1 (en) 1999-03-16 2003-03-11 The Regents Of The University Of California Glycosylated polyamines and methods of use therefor
EP1286661A2 (de) * 2000-06-09 2003-03-05 OSI Pharmaceuticals, Inc. Liposomale benzochinazolin thymidylat-synthaseinhibitor formulierungen
CN1578781A (zh) * 2001-09-26 2005-02-09 拜尔药品公司 用作抗糖尿病药物的1,8－萘啶衍生物
CN100434425C (zh) * 2005-03-09 2008-11-19 首都师范大学 4-喹唑啉酮衍生物及其在抗肿瘤药物中的应用
EP1754484A1 (de) 2005-08-17 2007-02-21 Dan Stoicescu Kondensierte Pyrimidinderivative als Inhibitoren der Folsäure-abhängiger Enzyme
CA2631704A1 (en) 2005-12-05 2007-06-14 Nitto Denko Corporation Polyglutamate-amino acid conjugates and methods
GB0525069D0 (en) * 2005-12-08 2006-01-18 Novartis Ag Organic compounds
EP2079739A2 (de) 2006-10-04 2009-07-22 Pfizer Products Inc. Pyrido[4,3-d]pyrimidin-4(3h)-onderivate als kalziumrezeptorantagonisten
EP1958632A1 (de) 2007-02-14 2008-08-20 Dan Stoicescu Kondensierte Pyrimidinderivaten zur Behandlung von Entzündungserkrankungen und Autoimmunerkrankungen
JP2010528122A (ja) * 2007-05-09 2010-08-19 日東電工株式会社 白金薬剤と結合されたポリマー
CA2683590A1 (en) * 2007-05-09 2008-11-20 Nitto Denko Corporation Compositions that include a hydrophobic compound and a polyamino acid conjugate
CN101707869A (zh) * 2007-05-09 2010-05-12 日东电工株式会社 具有多种药物的聚谷氨酸盐结合物和聚谷氨酸盐-氨基酸结合物
US8517760B2 (en) 2007-08-20 2013-08-27 Ford Global Technologies, Llc Cord wrap and power plug receptacle arrangement for inflator
US8146622B2 (en) 2007-08-20 2012-04-03 Ford Global Technologies, Llc Switch and hose-valve connection arrangement for vehicle temporary mobility kit
US8501242B2 (en) 2009-05-29 2013-08-06 University Of Florida Research Foundation Methods and compositions for treating neoplasia
CN101580501B (zh) 2009-06-01 2011-03-09 南京卡文迪许生物工程技术有限公司 3-(取代二氢异吲哚酮-2-基)-2,6-哌啶二酮的合成方法及其中间体
WO2011078226A1 (ja) * 2009-12-22 2011-06-30 協和発酵キリン株式会社 三環系化合物
AU2021356130A1 (en) 2020-10-08 2023-05-18 Redona Therapeutics, Inc. Benzo[h]quinazolin-4-amine and thieno[3,2-h]quinazolin-4-amine derivatives for the treatment of cancer
CN116547280A (zh) * 2020-10-08 2023-08-04 雷多纳治疗公司 用于治疗癌症的苯并[h]喹唑啉-4-胺和噻吩并[3,2-h]喹唑啉-4-胺衍生物

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UST862021I4 (en) * 1969-01-27 1969-05-27 Defensive publication
DE2202847A1 (de) * 1971-02-05 1972-08-17 Apaw Sa Speiseeismaschine,insbesondere fuer Familiengebrauch,Kleinbetriebe od.dgl.
DE3069468D1 (en) * 1979-12-19 1984-11-22 Nat Res Dev Quinazoline derivatives, processes for their preparation, compositions containing them and their use as anti-cancer agents
US4814335A (en) * 1982-12-30 1989-03-21 Biomeasure, Incorporated Antiviral compounds
GB8513754D0 (en) * 1985-05-31 1985-07-03 Jones T R Anti-cancer quinazoline derivatives
US4603186A (en) 1985-10-21 1986-07-29 The Standard Oil Company Tetrapolymers containing indene
GB8607683D0 (en) * 1986-03-27 1986-04-30 Ici Plc Anti-tumor agents
US4818819A (en) * 1986-10-20 1989-04-04 The Trustees Of Princeton University Process for the preparation of fused pyridine compounds
GB8707053D0 (en) * 1987-03-25 1987-04-29 Ici Plc Anti-tumour agents
US4857530A (en) * 1987-11-03 1989-08-15 Warner-Lambert Company Substituted quinazolinones as anticancer agents
US4902624A (en) * 1987-11-23 1990-02-20 Eastman Kodak Company Temperature cycling cuvette
GB8727737D0 (en) * 1987-11-26 1987-12-31 Ici Plc Antitumour agents
GB8829296D0 (en) * 1988-12-15 1989-01-25 Ici Plc Anti-tumour compounds
GB9013615D0 (en) * 1990-06-19 1990-08-08 Wellcome Found Pharmaceutical compounds
US5405851A (en) * 1990-06-19 1995-04-11 Burroughs Wellcome Co. Pharmaceutical compounds

Also Published As

Publication number Publication date
CA2085589A1 (en) 1991-12-20
ES2211851T3 (es) 2004-07-16
JPH05507704A (ja) 1993-11-04
KR930701415A (ko) 1993-06-11
IE912073A1 (en) 1992-01-01
JP2966929B2 (ja) 1999-10-25
DE69133088D1 (de) 2002-09-19
US5661155A (en) 1997-08-26
US5663337A (en) 1997-09-02
AP218A (en) 1992-09-27
AP9100283A0 (en) 1991-07-31
ATE260262T1 (de) 2004-03-15
CN1049215C (zh) 2000-02-09
WO1991019700A1 (en) 1991-12-26
ZA914676B (en) 1993-02-24
MC2290A1 (fr) 1993-07-14
PT98021B (pt) 1998-11-30
US6090941A (en) 2000-07-18
DK0535034T3 (da) 2002-12-09
IL98542A0 (en) 1992-07-15
AU639815B2 (en) 1993-08-05
NO924929L (no) 1992-12-18
KR0183042B1 (ko) 1999-05-01
CN1058208A (zh) 1992-01-29
CA2085589C (en) 2001-12-18
NO924929D0 (no) 1992-12-18
GB9013615D0 (en) 1990-08-08
HU9204011D0 (en) 1993-03-29
US6306865B1 (en) 2001-10-23
PL169927B1 (pl) 1996-09-30
PT98021A (pt) 1992-04-30
EP1199307A1 (de) 2002-04-24
ES2178632T3 (es) 2003-01-01
HU211265A9 (en) 1995-11-28
NZ238582A (en) 1993-12-23
EP0535034A1 (de) 1993-04-07
MY107001A (en) 1995-08-30
EP1199307B1 (de) 2004-02-25
FI925778A0 (fi) 1992-12-18
DE69133371D1 (de) 2004-04-01
FI925778A7 (fi) 1992-12-18
DK1199307T3 (da) 2004-06-14
HUT62273A (en) 1993-04-28
CS186391A3 (en) 1992-04-15
DE69133371T2 (de) 2005-01-27
AU8094391A (en) 1992-01-07
EP0535034B1 (de) 2002-08-14
DE69133088T2 (de) 2003-03-20
ATE222243T1 (de) 2002-08-15

Similar Documents

Publication Publication Date Title
IL98542A (en) Benzoquinazoline derivatives their preparation and pharmaceutical compositions containing them
ES2262087T3 (es) Compuestos heteroaromiticos biciclicos como inhibidores de proteina tirosina cinasa.
CA1285943C (en) Anti-tumour agents
DE60001811T2 (de) Antiimflammatorische indolderivate
KR100221011B1 (ko) 항-종양 화합물, 이의 제조 방법 및 이를 함유하는 약학 조성물
EP0637300A1 (de) Antitumor quinazoline
EP0318225B1 (de) 6-Arylaminomethylchinolin-Derivate und ihre Verwendung als Antitumorwirkstoff
NZ501920A (en) Indole derivatives as MCP-1 receptor antagonists
SK283952B6 (sk) Pyrido [2,3-D]pyrimidíny a farmaceutické kompozície na ich báze
JP2000508657A (ja) チロシンキナーゼの不可逆的阻害剤
US6762188B1 (en) Pharmaceutically active benzoquinazoline compounds
US5405851A (en) Pharmaceutical compounds
WO1995024395A1 (en) Quinoline derivatives as immunomodulators
JP2006519234A (ja) 新規化合物
JPWO2003002558A1 (ja) ウイルス感染治療剤

Legal Events

Date Code Title Description
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees